Atlas Trials

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Clinical trial NCT06074029 · UNKNOWN

Trial details

NCT number
NCT06074029
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Biliary Tract CancerImmune Checkpoint InhibitorPredictive Cancer Model
Start date
2021-12-01
Primary completion
2023-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.